Acorda Therapeutics (ACOR)
|
29.42
+0.42 (+1.45%)
|
|
|
|
ACOR analyst ratings
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ACOR price and earnings targets
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
ACOR earnings
Date
Actual
Expected
Prev Yr Qtr
10/31/2012
0.24
0.10
0.90
7/31/2012
0.11
0.12
0.07
5/3/2012
0.25
0.18
-0.02
Acorda Therapeutics (ACOR) Upgrades
Date
Analyst
Old Rating
New Rating
09/07/2010
Robert W. Baird
Neutral
Outperform
08/05/2009
Piper Jaffray & Co.
Neutral
Overweight
07/02/2009
Leerink Swann
Underperform
Outperform
11/03/2008
Robert W. Baird
Neutral
Outperform
06/19/2007
Banc of America Sec
Neutral
Buy
Acorda Therapeutics (ACOR) Downgrades
Date
Analyst
Old Rating
New Rating
12/14/2010
Baird
Outperform
Neutral
12/13/2010
Madison Williams
Reduce
Sell
10/21/2010
Leerink Swann
Outperform
Market Perform
02/18/2010
Leerink Swann
Outperform
Market Perform
01/25/2010
Piper Jaffray
Overweight
Neutral
06/23/2008
Friedman Billings
Outperform
Market Perform
Acorda Therapeutics (ACOR) New Coverage
Date
Analyst
Rating
05/18/2012
Goldman Sachs
Sell
11/11/2010
Madison Williams
Reduce
05/27/2010
Noble Financial
Buy
03/29/2010
Citi
Hold
09/28/2009
Merriman Curhan Ford
Neutral
03/24/2009
Hapoalim Securities
Market Outperform
